Abstract:In our current research work, a series of ten novel triaryl‐1,2,4‐Oxadiazole based derivatives 7 a–j were synthesized in during multistep reactions in good yields. All of the 7 a–j were fully characterized using spectroscopic methods (1H NMR, 13C NMR, MS, and IR). Anti‐diabetic effect of 7 a–j was tested by inhibition of α‐glucosidase, a key enzyme in diabetes disease treatment, and all compounds showed interesting bioactivity (IC50: 193.6 to 334 μM). Diabetes mellitus (DM) has become a growing health problem, across all globe. Many factors have contributed into this issue, among them inappropriate lifestyle, unhealthy eating habits and growing spiritual/mental concerns are to be rated higher. Likewise much research needed to be diverted in progress for treatment of DM. Herein, we report synthesis and antidiabetic activity evaluation of ten novel phenolic derivatives of triaryl‐1,2,4‐oxadiazole 7 a–j. The compounds have synthesized using multistep reactions in acceptable purity and yields. Final step was done using 1,3‐dipolar cycloaddition reaction between various Schiff bases and arylnitrile oxides. 7 a–j were characterized by spectroscopic methods (1H NMR, 13C NMR, MS and IR) and their purities were confirmed using elemental analysis. All 7 a–j were evaluated for their α‐Glucosidase inhibitory activity. All compounds showed higher activity in inhibiting the enzyme, in comparison to standard, acarbose. Compounds 7 e and 7 g exerted the best activity with the IC50 value of 193.6 and 222.0 μM respectively. Furthermore, enzyme kinetic study approach was adopted to judge the effect of 7 e on enzyme inhibition. Finally, docking simulations revealed the possible mode of interactions between 7 e and 7 g and enzyme active sites. Final conclusion of results showed that oxadiazole scaffold/s are a potential antidiabetic target.

Synthesis and biological evaluation of 3-arylcoumarin derivatives as potential anti-diabetic agents.

Design, Synthesis and Biological Evaluation of Novel Pyrimidinedione Derivatives As DPP-4 Inhibitors.

Synthesis & Alpha-Glucosidase Inhibitory & Glucose Consumption-Promoting Activities O Flavonoid-Coumarin Hybrids

Synthesis and Biological Evaluation of Novel Neoflavonoid Derivatives As Potential Antidiabetic Agents

Design, Synthesis and Biological Evaluation of GY3-based Derivatives for Anti-Type 2 Diabetes Activity.

Synthesis,Characterization and Antidiabetic Activities of Novel Genipin Derivatives

Synthesis and Biological Evaluation of 3-Arylcoumarins As Potential Anti-Alzheimer's Disease Agents.

Design, Synthesis, Molecular Docking and Hypoglycemic Activity of Novel Coumarin Analogues

Synthesis and Investigation on the Antidiabetic Effect of 3-Aryl-1-(5-methylisox Azol-3-ylamino)-1-(4-nitrophenyl) Propan-1-one

Synthesis and biological evaluation of novel ursolic acid analogues as potential α-glucosidase inhibitors

Synthesis and Evaluation of the Α-Glucosidase Inhibitory Activity of 3-[4-(phenylsulfonamido)benzoyl]-2h-1-benzopyran-2-one Derivatives

Synthesis and in vitro evaluation of 12-(substituted aminomethyl) berberrubine derivatives as anti-diabetics

Preparation of Novel 3,4,5‐Triaryl‐1,2,4‐Oxadiazole Derivatives: Molecular Docking and α‐Glucosidase assessment

Synthesis and Evaluation of Coumarin-Chalcone Derivatives as α-Glucosidase Inhibitors

Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents.

Design, Synthesis and in Vivo Evaluation of Novel C‐Aryl Glucosides As Potent Sodium‐Dependent Glucose Cotransporters Inhibitors for the Treatment of Diabetes

Synthesis and activity of arylcoumarin derivatives with therapeutic effects on diabetic nephropathy

[Synthesis and Preliminary Evaluation of Antidiabetic Activity of 4-(3-(4-Bromophenyl)-3-oxo-1-arylpropylamino)-n-(5-methylisoxazol-3-yl)benzenesulfonamide].

Synthesis of 4-thiosubstituted flavan derivatives and their hypoglycemic activities

Synthesis and antihyperglycemic evaluation of various protoberberine derivatives.

Novel tetrahydrobenzo[b]thiophen-2-yl)urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti-hyperglycemic evaluation